Hib vaccine: Should it be introduced in the national immunization program?

Introduction of Hib containing pentavalent vaccine in national immunization program of India: the concerns and the reality!

The Global Alliance for Vaccines and Immunization (GAVI) recently sanctioned funds worth US$ 165 million for introduction of a pentavalent combination vaccine (containing Diphtheria, Tetanus, Pertussis, Hepatitis B and Hib antigens) in to the routine immunization program of India(1). This combination vaccine will first be introduced in ten states (Andhra Pradesh, Himachal Pradesh, Jammu & Kashm...

Rubella--should It Be a Priority in the National Immunization Programmes?

Rubella is a mild infection of childhood and young adults with 75% of cases occurring in age group 15-45 years. In unvaccinated populations, rubella usually occurs in spring with epidemics in 6-9 years cycles. Rubella has devastating effects on growing foetus if contracted by women in the first trimester of pregnancy. Perinatal infection of Rubella contributes to 2-3% of all congenital anomalie...

The Human Papillomavirus Vaccine: Should It Be Mandatory or Voluntary?

Cuba's National Immunization Program.

The National Immunization Program (NIP) begun in 1962 has considerably reduced the infectious disease burden in Cuba over the years, especially among children. The Ministry of Public Health estimates that some 560,000 children would have contracted these diseases, some with fatal outcomes, had it not been for the aggressive vaccination strategy begun 45 years ago and developed since then.

The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule

BACKGROUND WHO recommended incorporation of Haemophilus influenzae type b (Hib) vaccination into immunization program. Indonesia would adopt Hib as a National Immunization Program in 2013. We aimed at analyzing immunogenicity, safety, and consistency of a new combined DTP-HB-Hib (diphtheria-tetanus-pertussis-Hepatitis B-Haemophilus influenza B) vaccine. METHODS A prospective, randomized, doub...